Alex Gitlin, M.D., Ph.D. is currently a 3rd year resident in clinical pathology at Stanford University. Prior to Stanford, Alex received his M.D. from Weill Cornell Medicine (2017) and his Ph.D. from Rockefeller University (2016) as part of the Medical Scientist Training Program (MSTP) at the Tri-Institutional M.D.-Ph.D. program. During his graduate training, Dr. Gitlin focused on the cellular and molecular mechanisms underlying germinal center reactions and the formation of long-lived humoral immunity. His work elucidated the mechanisms by which CD4+ T cells induce selective clonal expansion of germinal center B cells during the immune response. Currently, Alex's clinical and research interests lie in understanding how inflammatory signaling pathways regulate different forms of programmed cell death and inflammation.
Honors & Awards
Harold M. Weintraub Graduate Student Award, Fred Hutchinson Cancer Research Center (2016)
Ruth L. Kirchstein National Research Service (F30), National Institutes of Allergy and Infectious Diseases, NIH (2014-2017)
Herman L. Jacobius Award for Excellence in Pathology, Weill Cornell Medicine (2017)
Medical Scientist Training Program, NIH (2009-2017)